sarcomas

money flying in
Biotech

ADC biotech adds on $135M series B

TCGX led Adcendo's oversubscribed series B financing, with several existing investors—including RA Capital Management and Novo Holdings—in tow.
Gabrielle Masson Nov 25, 2024 7:00am
mechanical gears shifting

Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

Nov 13, 2024 2:57pm
finch canary cage free bird release

FDA frees Salarius’ rare cancer asset from clinical hold

May 9, 2023 11:20am
Liposarcoma sarcoma

Salarius pauses enrollment of sarcoma trial after patient death

Oct 18, 2022 9:50am
cancer newspaper

Adaptimmune's T-cell therapy clears efficacy bar in solid tumors

Nov 12, 2021 7:05am
Laboratory

ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas

May 19, 2021 5:00pm